196 related articles for article (PubMed ID: 12663238)
1. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt.
Trevisani F; Merli M; Savelli F; Valeriano V; Zambruni A; Riggio O; Caraceni P; Domenicali M; Bernardi M
J Hepatol; 2003 Apr; 38(4):461-7. PubMed ID: 12663238
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
Colombato LA; Spahr L; Martinet JP; Dufresne MP; Lafortune M; Fenyves D; Pomier-Layrargues G
Gut; 1996 Oct; 39(4):600-4. PubMed ID: 8944572
[TBL] [Abstract][Full Text] [Related]
3. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS).
Nolte W; Ehrenreich H; Wiltfang J; Pahl K; Unterberg K; Kamrowski-Kruck H; Schindler CG; Figulla HR; Buchwald AB; Hartmann H; Ramadori G
Liver; 2000 Feb; 20(1):60-5. PubMed ID: 10726962
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison.
Helton WS; Maves R; Wicks K; Johansen K
Arch Surg; 2001 Jan; 136(1):17-20. PubMed ID: 11146768
[TBL] [Abstract][Full Text] [Related]
5. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results.
Rodríguez-Laiz JM; Bañares R; Echenagusia A; Casado M; Camuñez F; Pérez-Roldán F; de Diego A; Cos E; Clemente G
Dig Dis Sci; 1995 Oct; 40(10):2121-7. PubMed ID: 7587778
[TBL] [Abstract][Full Text] [Related]
6. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
[TBL] [Abstract][Full Text] [Related]
7. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
8. Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.
Montomoli J; Holland-Fischer P; Bianchi G; Grønbaek H; Vilstrup H; Marchesini G; Zoli M
World J Gastroenterol; 2010 Jan; 16(3):348-53. PubMed ID: 20082481
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis.
Busk TM; Bendtsen F; Poulsen JH; Clemmesen JO; Larsen FS; Goetze JP; Iversen JS; Jensen MT; Møgelvang R; Pedersen EB; Bech JN; Møller S
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G275-G286. PubMed ID: 29074483
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt placement increases feasibility of colorectal surgery in cirrhotic patients with severe portal hypertension.
Menahem B; Lubrano J; Desjouis A; Lepennec V; Lebreton G; Alves A
Dig Liver Dis; 2015 Jan; 47(1):81-4. PubMed ID: 25445406
[TBL] [Abstract][Full Text] [Related]
11. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
[TBL] [Abstract][Full Text] [Related]
12. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
13. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on blood volume distribution in patients with cirrhosis.
Busk TM; Bendtsen F; Henriksen JH; Fuglsang S; Clemmesen JO; Larsen FS; Møller S
Dig Liver Dis; 2017 Dec; 49(12):1353-1359. PubMed ID: 28729141
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic vascular shunting for portal hypertension: early experience with the transjugular intrahepatic porto-systemic shunt.
Rogers CG; Paolini RM; O'Leary JP
Am Surg; 1994 Feb; 60(2):114-7. PubMed ID: 8304641
[TBL] [Abstract][Full Text] [Related]
15. Post-surgical shunt hepatopulmonary syndrome in a case of non-cirrhotic portal hypertension: lack of efficacy of shunt reversal.
Hannam PD; Sandokji AK; Machan LS; Erb SR; Champion P; Buczkowski AK; Scudamore CH; Steinbrecher UP; Chung SW; Weiss AA; Yoshida EM
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1425-7. PubMed ID: 10654806
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
17. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
18. Functional hepatic flow can predict the hepatic reserve function in surgical cirrhotic patients.
Xingjiang W; Weiwei D; Jianmin C; Jianming H; Jieshou L
J Invest Surg; 2009; 22(3):178-82. PubMed ID: 19466654
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic porto-systemic shunt is a risk factor for liver dysplasia but not hepatocellular carcinoma: a retrospective study of explanted livers.
Borentain P; Garcia S; Gregoire E; Vidal V; Ananian P; Ressiot E; Hardwigsen J; Bartoli JM; Moulin G; Botta-Fridlund D; Le Treut YP; Gerolami R
Dig Liver Dis; 2015 Jan; 47(1):57-61. PubMed ID: 25308609
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
